Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis (Q39972640)

16 September 2017

Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis (English)

1 reference

16 September 2017

0 references

1 reference

R L Novak

1

1 reference

PubMed ID

18551146

16 September 2017

A C Phillips

series ordinal

2

1 reference

16 September 2017

13 June 2008

1 reference

16 September 2017

1 reference

16 September 2017

15

1 reference

16 September 2017

11

1 reference

16 September 2017

713-722

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2008.25

16 September 2017

0 references

cites work

Cancer gene therapy: fringe or cutting edge?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Genome regulation by polycomb and trithorax proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

YEAF1/RYBP and YAF-2 are functionally distinct members of a cofactor family for the YY1 and E4TF1/hGABP transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Rybp/DEDAF is required for early postimplantation and for central nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Rybp, a polycomb complex-associated protein, is required for mouse eye development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

The death effector domain protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Gene therapy: twenty-first century medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Optimizing first-line treatment options for patients with advanced NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Primary bone osteosarcoma in the pediatric age: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

The signaling adaptors and pathways activated by TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Control of apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Cellular response to etoposide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Potential and caveats of TRAIL in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

Cancer-selective therapy of the future: apoptin and its mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

inferred from DOI database lookup

7 January 2021

based on heuristic

The Drosophila RYBP gene functions as a Polycomb-dependent transcriptional repressor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.25

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2008.25

1 reference

16 September 2017

1 reference

PubMed ID

18551146